18F-FDG PET-CT in the diagnosis of tumor thrombus: Can it be differentiated from benign thrombus?

Punit Sharma, Rakesh Kumar, Sunil Jeph, Sellam Karunanithi, Niraj Naswa, Arun Gupta, Arun Malhotra

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

OBJECTIVE: The correct diagnosis of tumor thrombosis and its differentiation from benign thrombus can change patient management and prevent unnecessary anticoagulation treatment. This study was aimed at evaluating the role of fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in the diagnosis of tumor thrombosis, and its differentiation from benign thromboembolism. METHODS: We conducted a retrospective review of FDG PET-CT scans of patients who underwent the study for staging/restaging of a known malignancy and had FDG-avid thrombosis. Maximum standardized uptake value (SUVmax) of the thrombus, SUVmax of tumor (if any), and SUVmax of mediastinal blood pool were calculated. PET-CT results were confirmed with clinical follow-up, structural imaging, and histopathology when available. RESULTS: A total of 24 patients (15 male and nine female) with a mean age of 43.8 years (range: 3-72 years; median: 47.5 years) were evaluated. On the basis of structural imaging and clinical follow-up, 10 patients had benign and 14 patients had tumor thrombosis. On FDG PET-CT, uptake in the thrombus was linear in 18 patients and focal in six patients. The most common site of thrombosis was the inferior vena cava. The mean SUVmax was 3.2 (range: 2.3-4.6; median: 3.3) in the benign thrombosis group and was 6.0 (range: 2.3-13.8; median: 3.3) in the tumor thrombosis group. The difference in SUVmax was significant (P=0.013). On receiver operating characteristic analysis, a cut-off SUVmax of 3.63 (sensitivity: 71.4% and specificity: 90%) was obtained to differentiate tumor thrombus from benign thromboembolism. In six patients, FDG PET-CT detected occult vascular thrombosis. CONCLUSION: FDG PET-CT can detect active tumor thrombosis and is helpful in differentiating it from benign thrombus.

Original languageEnglish (US)
Pages (from-to)782-788
Number of pages7
JournalNuclear Medicine Communications
Volume32
Issue number9
DOIs
StatePublished - Sep 2011

All Science Journal Classification (ASJC) codes

  • Radiology Nuclear Medicine and imaging

Fingerprint

Dive into the research topics of '<sup>18</sup>F-FDG PET-CT in the diagnosis of tumor thrombus: Can it be differentiated from benign thrombus?'. Together they form a unique fingerprint.

Cite this